A detailed history of National Bank Of Canada transactions in Abbott Laboratories stock. As of the latest transaction made, National Bank Of Canada holds 633,275 shares of ABT stock, worth $71.9 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
633,275
Previous 565,248 12.03%
Holding current value
$71.9 Million
Previous $64.2 Million 2.42%
% of portfolio
0.1%
Previous 0.11%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$100.73 - $112.44 $6.85 Million - $7.65 Million
68,027 Added 12.03%
633,275 $65.8 Million
Q1 2024

May 13, 2024

SELL
$109.52 - $120.96 $52.1 Million - $57.5 Million
-475,411 Reduced 45.68%
565,248 $64.2 Million
Q4 2023

Feb 06, 2024

SELL
$90.19 - $110.4 $1.72 Million - $2.11 Million
-19,083 Reduced 1.8%
1,040,659 $115 Million
Q3 2023

Oct 10, 2023

BUY
$95.53 - $114.62 $4.81 Million - $5.77 Million
50,306 Added 4.98%
1,059,742 $103 Million
Q2 2023

Jul 26, 2023

BUY
$100.78 - $112.29 $15 Million - $16.7 Million
149,087 Added 17.33%
1,009,436 $110 Million
Q1 2023

Apr 12, 2023

BUY
$96.86 - $114.01 $188,489 - $221,863
1,946 Added 0.23%
860,349 $87.1 Million
Q4 2022

Jan 24, 2023

BUY
$95.06 - $111.52 $57.5 Million - $67.4 Million
604,527 Added 238.12%
858,403 $0
Q3 2022

Oct 13, 2022

SELL
$96.76 - $112.03 $3.92 Million - $4.53 Million
-40,465 Reduced 13.75%
253,876 $24.7 Million
Q2 2022

Jul 28, 2022

BUY
$102.07 - $123.37 $10.1 Million - $12.2 Million
98,616 Added 50.38%
294,341 $32.1 Million
Q1 2022

May 05, 2022

BUY
$114.02 - $139.04 $932,455 - $1.14 Million
8,178 Added 4.36%
195,725 $20.8 Million
Q4 2021

Jan 24, 2022

BUY
$115.53 - $141.46 $21.7 Million - $26.5 Million
187,547 New
187,547 $26.3 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.